During the two US presidential elections in which George W. Bush participated, the topic of embryonic stem cell research was one of the hottest topics in the debate. Proponents of germ cell research emphasize the potential for innovative treatments for victims of paralysis, Parkinson’s disease, cancer and other conditions. Opponents of the study argued that as a market for newly harvested embryos was created, it would lead to an increase in abortion rates. However, the question of whether embryonic cell research is needed is lost in the debate. Stem cell therapy has been studied and developed for decades using mature stem cells and cord blood. There are many advantages to using these cells over germ cells, including the fact that the embryos are not destroyed during the collection process, but most important from a medical point of view is the stability of adult blood cells and umbilical cord. And predictability.
To date, a single treatment developed by embryonic cells has not even been shown to be minimally effective. This is due to the fact that these stem cells are badly umbilcial cord scottsdale underdeveloped because they were initiated only during the life cycle. As these cells develop, a series of problems are more likely to occur without the help of the mother’s fully developed body. In contrast, adult stem cells are already fully developed and are very stable for use in medical treatment. Umbilical cord blood cells, which are taken from the umbilical cord blood, are supplied by the mother’s body and are similarly stable. In fact, medicine has been very successful in studying adult and cord blood stem cells, with more than 70 treatments passing peer review and proven to be effective since the late 1990s.
The more well-known symptoms that gave positive results on adult cell therapy include cancer of the brain, testis and ovaries, Hodgkin lymphoma and non-Hodgkin lymphoma, type I diabetes, Crohn’s disease, coronary artery disease, liver cirrhosis, Includes liver cirrhosis and terminal stage. Stage bladder disease.
The great success of adult and cord blood stem cell therapy should provide sufficient evidence to completely end the debate, as opposed to the complete failure of its embryonic counterpart. If success has already been achieved in another way, you don’t have to keep talking about the possibility of a failed idea.